Entera Bio Ltd Archives - BioPharmaJournal

Entera Unveils EB613 Phase 2 Biomarker Data

Kate Hudson - March 16, 2021 0

ObsEva SA (NASDA: OBSV) Announce Corporate Restructuring And Resignation of Chief...

Kate Hudson - August 11, 2022 0

ObsEva SA (NASDA: OBSV) has announced plans to commence corporate restructuring and refocus its commercial and development strategy. FDA points to shortfalls in ObSeva’s linzagolix...

Why Crypto Stocks May be the Best Route to Monetizing the...

August 10, 2022

Evofem Bioscience Inc. (NASDAQ: EVFM) Commends US Multi-Agencies For Clarifying Birth...

August 10, 2022

Top CBD, Cannabis, and Metaverse Momentum Stories Surface in August Rally...

August 9, 2022

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Partners with Kenya Medical Research...

August 9, 2022

ObsEva SA (NASDA: OBSV) Announce Corporate Restructuring And Resignation of Chief…

Evofem Bioscience Inc. (NASDAQ: EVFM) Commends US Multi-Agencies For Clarifying Birth…

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Partners with Kenya Medical Research…

GeoVax Labs Inc. (NASDAQ: GOVX) Publishes Its Efficacy Study of Modified…

Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development…

Why Your Body Needs Nitric Oxide Boost Beets For More Energy…

Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…

Cutting Edge Power announces an all-new version of its popular Smart…

Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount

Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…

Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…

Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…

Micro and Macro Tailwinds Converge for KULR

ISWH and the Rebirth of the Crypto Cycle

Tag: Entera Bio Ltd